Kidney Cancer: Non–Clear Cell Histology

Expanding Treatment Horizons: Novel Approaches in RCC and Non-Clear Cell DiseaseПодробнее

JCO PO Article Insights: Germline Pathogenic Variants in Renal Cell CarcinomaПодробнее

Topline Bio x Uromigos: 2024 Year in Review - ESMO: RCCПодробнее

Dr McGregor on the Updated NCCN Guidelines for Non–Clear Cell RCCПодробнее

"Immunobiology of Kidney Cancer: From the Lab to the Clinic"Подробнее

KCRS24 Session Three - State of the Science in Kidney Cancer ResearchПодробнее

SESSION 5: CABOSUN II & KEYNOTE-B61 Results for Non-Clear Cell RCC| Dr Kunal Jonbanputra, MOC MumbaiПодробнее

EMUC24 kidney cancer special: Prof. Bedke talks about cytoreductive nephrectomy, and the SUNNIFOR...Подробнее

Navigating adjuvant therapy in non-clear cell renal cell carcinomaПодробнее

Advanced Non-Clear Cell Renal Cell CarcinomaПодробнее

Non-Clear Cell Kidney Cancer: Dr. Elizabeth Henske Discusses Variant Histologies & TherapiesПодробнее

Biology of Non-clear Cell Renal Cancer Subtypes: KCRS23 Session One | KidneyCANПодробнее

#GUPATH Update on the Classification of Renal Tumors: WHO 2022 and beyondПодробнее

PURSUE 1-R- Renal Cell Tumors- Part 1 ( A WHO 5th Edition 2022 oriented approachПодробнее

Clearing Up Non-Clear Cell Renal Cell Carcinoma ManagementПодробнее

Yale Cancer Center Grand Rounds | December 13, 2022Подробнее

Promising results of cabozantinib plus nivolumab in non-clear cell RCCПодробнее

KEYNOTE-B61 Study Results and a Focus on Non-Clear Cell Kidney CancerПодробнее

KEYNOTE-B61: first-line lenvatinib + pembrolizumab in non-clear cell RCCПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее